PATRICIA MOONEY: Open Payments
NPI 1700470200 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,529 in 89 payments from 37 companies in 2025. Trend: 2023 $1,450 · 2024 $909 · 2025 $2,529
Food & beverage: $2,444Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $356 |
| Novartis Pharmaceuticals Corporation | 10 | $232 |
| Caris MPI, Inc. | 4 | $224 |
| ABBVIE INC. | 7 | $160 |
| Celgene Corporation | 4 | $114 |
| Exelixis Inc. | 3 | $104 |
| GlaxoSmithKline, LLC. | 4 | $101 |
| Merck Sharp & Dohme LLC | 3 | $87 |
| Daiichi Sankyo Inc. | 3 | $76 |
| BeOne Medicines USA, Inc. | 3 | $76 |
Products named: MI CANCER SEEK, TECVAYLI, ERLEADA, CABOMETYX, SCEMBLIX, Enhertu, VENCLEXTA, BRUKINSA.
Industry payments across CA — which companies pay providers there.
